Abstract
Background: One of the major paths for drug development is the study of bioactivities of natural products. Therefore, the aim of this study was to compare the cytotoxic effects of aqueous extract of whole Cuscuta chinensis Lam., which is a traditional medicinal herb commonly used in Iran and other oriental countries, on the human caucasian acute lymphoblastic leukemia (CCRF-CEM) and another human lymphocyte, Jurkat (JM) cell lines.
Methods: In vitro cytotoxic screening with various concentrations (0, 0.1, 1, 10, 25 and 50 µg/ml) of the extract was performed using microscope and methyl tetrazolium bromide test (MTT).
Results: The minimum effective concentration of the plant extract was 1 µg/ml, and increasing the dose to 10 µg/ml induced increasingly stronger effects. The inhibitory concentration 50% (IC^sub 50^) of the extract against CCRF was about 3 µg/ml in 24 hours and 2.5 µg/ml in 48 hrs. In contrast, the extract did not have cytotoxic effect for the JM cells at these doses.
Conclusion: The findings of the present study suggest that C. chinensis is toxic against CCRF-CEM and JM tumor cells. Whether or not such effects can be employed for the treatment of such tumors must await future studies.
Iran J Med Sci 2010; 35(4): 310-314.
Keywords * Cuscuta * acute lymphoblastic leukemia * antitumor agent * MTT formazan
Introduction
Nowadays, the use of traditional herbal medicine as alternative treatment has been revived all over the world. People have started to use some of the commonly well-known herbs crude extract as daily food supplement and tonic. However, the effects of a lot of such herbs on the body system have not been documented. Therefore, researchers have started to study the biological properties of the traditional herbs.1-3 One of these herbs is Cuscuta chinensis Lam., which is a delicate, twining, glabrous, yellowish-green, and thread-like parasitic herb belonging to the family Convolvulaceae, which is distributed in tropical and temperate regions. The herb is known as Aftimun in India's traditional medicine.4,5
Cuscuta chinensis is an important herbal medicine that is used as tonic and aphrodisiac to nourish the liver and kidneys, and to treat impotence and seminal emission.6,7 Moreover, it is considered to have antitumor effects in prostate cancer, skin carcinomas and papillomas, 5,8 antimutagenic activity against heterocyclic amines, cytotoxicity effect for lymphoblastic- like tumor cell line (HL60),9 and immunostimulating and antioxidant functions.6, 10 Although, several studies,5,8,9 have demonstrated the biological functions of C. chinensis as antitumor, a number of other observations showed that C. chinensis stimulated the proliferation of epidermoid carcinoma (MCF-7) cell line, human breast cancer (T47D) cell line,11 and lymphocytes and rat bone cells.10,12 In addition, Aftimun was shown to activate and differentiate human osteoblast-like MG-63 cells and rat pheochromocytoma PC12 cells.13,14
There is, however, no direct experimental evidence for the cytotoxic effect of aqueous extract of whole C. chinensis on tumor cells. Therefore, the present study was designed to investigate in vitro cytotoxic effect of aqueous extract from whole C. chinensis on human caucasian acute lymphoblastic leukemia (CCRF-CEM) and a human lymphocyte, Jurkat (JM), cell lines using methyl tetrazolium bromide test (MTT).
Materials and Methods
Preparation of the Plant Extract
Seeds of C. chinensis were purchased from a local herbal medicine grocery (Hamadan, Iran) and authenticated by one of the authors; KR. The seeds were grown on Alyssum campestre L., and the whole part of the fresh C. chinensis was used to prepare the aqueous extract. Two hundred grams of the plant were mixed with 50 ml of distilled water, and the extract obtained through pressing and grinding of the plant using stainless steel press. The extract was filtered twice using a Whatman filter paper, and then sterilized with a 0.2 µm filter. The moisture of the extract was determined by placing 4 grams of the final extract in an oven at 50°C for 2 h. The extract was then weighed, and the weight loss was used as a moisture indicator. The final extract contained 88 mg/ml of the plant.
Cell Lines
CCRF-CEM and JM cell lines were obtained from the National Cell Bank of Iran (NCBI) at Pasteur Institute. The cells were maintained, cultured and incubated in RPMI1640 medium (Gibco-BRL, Australia) with 100 U/ml penicillin G (Hayan, Iran), 10% FCS (Gibco- BRL, Australia), 100 µg/ml streptomycin (Hayan, Iran) at temperature of at 37°C, a CO2 of 5%, and a humidity of 90 % throughout the study. The cells viability was assessed by the trypan blue exclusion method.2
Microscopic analysis
CCRF-CEM and JM cells were seeded into the 6-well plates. Each well contained 5×10^sup 4^ cells/ml, which were incubated for 4 h to allow their adaptation and treated with the various concentrations (0, 0.1, 1, 10, 25 and 50 µg/ml) of the plant extract for 24 and 48 hours. After the incubation of the cells with the extract, morphological changes and granularity of the cells were examined by an inverted microscope.14
Methyl tetrazolium bromide Cytotoxicity Assay
CCRF-CEM or JM cells (n=2.5×10^sup 5^ cells) were seeded into the 12-well plates, and incubated with 0.5 ml medium per each well for 4 hours. Then, cells were exposed to the different concentrations (0, 0.1, 1, 10, 25 and 50 µg/ml) of the plant extract for 24 and 48 h. After the incubation of the cells with the extract, each vial of MTT reagent (Sigma, USA) was reconstituted with 3 ml of phosphate buffer solution (PBS) with a pH=8, and added in an equal volume to 10% of the culture medium. The cells were returned to incubator for 4 hours. Then, the plates were removed from the incubator and the resulting formazan crystals were dissolved by adding MTT solubilization solution in equal volume of the original culture medium. MTT formazan crystals were completely dissolved by pipetting up and down. The absorbance was measured at the wavelength of 570 nm,15 using UV-vis spectrophotometer (Spectronic Genesys, USA). The cells' viability was determined according to the optical density (OD) of the wells which contained no extract. The inhibitory concentration 50% (IC50) was defined as the minimum concentration of the extract that reduced viability of the incubated cells after 24 and 48 h by 50%.2,9
Results
The CCRF-CEM and JM cell lines incubated with C. chinensis extract showed a low growth rate. Compared to JM cells, the CCRF-CEM cell line showed a significant increase in death and granularity (figure 1). As shown in figure 2, the viability of the CCRF-CEM cells was also reduced compared to the JM cells. The minimum effective concentration for the plant extract was 1 µg/ml, and increasing the dose to 10 µg/ml showed increasingly stronger effects. As shown in figure 2, IC50 of the extract for CCRF was 3 µg/ml after 24 h and 2.5 µg/ml after 48 h incubation. The cytotoxic effect of the plant extract was not significantly different after 24 or 48 h of incubation.
The extract did not reduce the viability of JM cells, and did have no IC50 that could be determined at the range of used concentrations of the extract.
Discussion
To evaluate the cytotoxic effect of the aqueous extract of whole C. chinensis on two cell lines, the viability of the human caucasian acute lymphoblastic leukemia (CCRF-CEM) and a human lymphocyte (JM) cell lines were tested using MTT assay. The significant reduction of CCRF-CEM cell line viability compared with JM cells showed that the extract induced cytotoxicity on CCRF-CEM with minimal effect on other human lymphocyte cell line. To our knowledge, there is only one somehow similar research which reported that the methanolic extract of C. chinensis had cytotoxic effect against a tumor cell line, HL60, with an inhibitory concentration 100% (MIC100) of 4.0 µg/ml.9 Therefore, the potent cytotoxic activity of the aqueous extract of whole C. chinensis is reported for the first time in this study. Our results are also generally in agreement with those of a published study,5 which showed that the oral administration of a hot water extract of C. chinensis whole plant (1 g/kg body weight) thrice a week on 7, 12- dimethylbenz[a]anthracene (DMBA)-induced skin papillomas and carcinomas in Swiss albino mice markedly delayed the appearance and retarded the growth of papillomas and the incidence of carcinoma, relative to a control group. Moreover, the findings of the present study are similar to those studies, which demonstrated that equiguard, a dietary supplement comprised of standardized extracts from nine herbs including C. chinensis (ethanol extract of seed), significantly reduced prostate carcinoma cell growth,8 induced apoptosis,8 showed antioxidant activity,6 and indirectly stimulated the antitumor activity.16,17
The results of this study are, however, in contrast with those of a number of previous studies.10-12 When added to the bone cell culture, crude extract of C. chinensis promoted the proliferation and differentiation of osteoblasts from their precursor cells.12 Moreover, cuscutic resinoside A, a resin glycoside isolated from the seeds of C. chinensis showed potency for stimulating MCF-7 and T47D human breast cancer cells at a concentration of 10 µM.11 As well, three crude polysaccharide fractions prepared from the seeds of C. chinensis by hot water extraction showed a stimulating effect on concanavalin A or lipopolysaccharide induced mitogenic activity of lymphocytes.10
The pharmacological effects of C. chinensis have been attributed to the main constituents of C. chinensis including flavonoids, saccharide, alkaloids, lignans, and resin glycosides.10,11,18,19 It seems that the exact component(s) responsible for the cytotoxic effects may be found in the both aqueous and alcoholic extracts of the whole part of the plant. As evidence from this and others experimental studies,5,8,9 suggest the exact component might be mahanine.
Mahanine is an interesting food component exhibiting a wide variety of bioactivities like cytotoxicity against HL60 cells.9 It is expected that C. chinensis may contain mahanine and contribute to increase cytotoxicity and reduce cancer risks. To elucidate whether or not C. chinensis contains this component further investigations are required.
Conclusion
The findings of the present study suggest that C. chinensis is toxic against CCRF-CEM and JM tumor cells. Whether or not such effects can be employed for the treatment of such tumors must await future studies.
Acknowledgment
The authors would like to thank Mr. Saemin for his suggestion to study the possible anticancer effects of the plant. This work was financially supported by the Vice-Chancellor for Research, Hamadan University of Medical Sciences, Hamadan, Iran.
Conflict of Interest: None declared
References
1 Kong YC, Chen DS. Elucidation of Islamic drugs in Hui Hui Yao Fang: a linguistic and pharmaceutical approach. J Ethnopharmacol 1996; 54: 85-102.
2 Yeap SK, Alitheen NB, Ali AM, et al. Effect of Rhaphidophora korthalsii methanol extract on human peripheral blood mononuclear cell (PBMC) proliferation and cytolytic activity toward HepG2. J Ethnopharmacol 2007; 114: 406-11.
3 Yen FL, Wu TH, Lin LT, et al. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem Toxicol 2008; 46: 1771-7.
4 Anis E, Anis I, Ahmed S, et al. Alphaglucosidase inhibitory constituents from Cuscuta reflexa. Chem Pharm Bull (Tokyo) 2002; 50: 112-4.
5 Nisa M, Akbar S, Tariq M, Hussain Z. Effect of Cuscuta chinensis water extract on 7,12-dimethylbenz[a]anthracene-induced skin papillomas and carcinomas in mice. J Ethnopharmacol 1986; 18: 21-31.
6 Yen FL, Wu TH, Lin LT, Lin CC. Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminopheninduced hepatotoxicity in rats. J Ethnopharmacol 2007; 111: 123-8.
7 Du XM, Kohinata K, Kawasaki T, et al. Components of the ether-insoluble resin glycoside-like fraction from Cuscuta chinensis. Phytochemistry1998; 48: 843-50.
8 Hsieh TC, Lu X, Guo J, et al. Effects of herbal preparation Equiguard on hormone
Fatemeh Zeraati1, Alireza Zamani2, Mohammad Taghi Goodarzi3, Seyed Mansour Malakouti Hashjin4, Kaivan Razzaghi5
1Departments of Pharmacology,
2Immunology, 3Biochemistry & Nutrition,
4Physiology,
School of Medicine,
Hamadan University of Medical Sciences,
5Research Center for Agriculture and
Natural Resources,
Hamadan, Iran.
Correspondence:
Alireza Zamani PhD,
Department of Immunology,
School of Medicine,
Hamadan University of Medical Sciences,
Hamadan, Iran.
Tel: +98 811 8276295-8, ext: 338
Fax: +98 811 8276299
Email: [email protected]
Received: 21 April 2010
Revised: 11 October 2010
Accepted: 21 October 2010
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Dr Ali Akbari Sari, Director of The Commission for Accreditation & Improvement of Iranian Medical Journals Dec 2010